Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| ANV 2025-28 | Registry Identifier | Comitato Etico Territoriale Area Nord Veneto |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Prospective, exploratory, multicenter pilot study investigating the structural and functional connectome in patients with Friedreich's Ataxia (FRDA) using high-density electroencephalogram (HD-EEG). The aim is to identify neurophysiological biomarkers and analyze the relationship between cortical connectivity, cognitive functioning, and clinical severity, particularly in response to rehabilitation treatment.
Friedreich's Ataxia (FRDA) is a progressive neurodegenerative disease caused by mutations in the FXN gene, resulting in a reduction in the mitochondrial protein frataxin and a dysfunction in iron homeostasis. In addition to motor and sensory impairments, FRDA also results in cognitive and emotional deficits. Pathophysiologically, it is associated with cerebellar degeneration and alterations in cerebello-cortical networks.
The present study proposes a novel HD-EEG-based approach to analyze brain activity at resting-state and during the performance of a motor task (task-based) in subjects with FRDA. Thirty patients with confirmed genetic diagnosis, age between 8 and 60 years, and SARA score <30 will be recruited. EEG recordings will be performed in resting condition and during an upper limb motor task.
In addition to neurophysiological measures, each participant will undergo a comprehensive neuropsychological evaluation, including memory, attention, language, visuospatial skills, praxis, executive functions, emotional and personality aspects. Connectivity data will be correlated with cognitive profiles and scores on the SARA and mFARS clinical scales.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with Friedreich's ataxia undergoing HD-EEG and neurofunctional rehabilitation. | Experimental | This arm includes patients with a confirmed genetic diagnosis of Friedreich's Ataxia (FRDA), aged between 8 and 60 years, with SARA scale scores below 30. Participants undergo high-density electroencephalogram (HD-EEG) recording under resting conditions and during a motor task, as well as a comprehensive neuropsychological and emotional assessment. All follow an intensive rehabilitation program lasting 3-4 weeks. HD-EEG recordings are repeated after treatment and one year later to assess longitudinal changes in functional connectivity and identify potential biomarkers associated with clinical progression. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| HD-EEG recordings, combined with cognitive and motor assessment | Device | Participants will undergo high-density EEG (HD-EEG) recordings under two conditions: at rest and while performing an upper limb motor task. The data obtained will be used to reconstruct source cortical activity and derive patterns of functional connectivity, using advanced neurophysiological analysis techniques, including the Avalanche Transition Matrix (ATM). In addition, patients will complete a neuropsychological assessment and participate in an intensive multidisciplinary rehabilitation program lasting 3 to 4 weeks, depending on age. The intervention aims to assess changes in the functional organization of the brain before and after treatment, as well as one year later, in order to explore potential biomarkers of disease progression. |
| Measure | Description | Time Frame |
|---|---|---|
| Connectivity profile derived from HD-EEG in subjects with FRDA. | Characterization of alterations in the connectome derived from the HD-EEG of subjects with FRDA compared with matched controls; | From enrollment to the end of treatment at 3 to 4 weeks and after 1 year of follow-up |
| Functional activity derived from HD-EEG in subjects with FRDA. | Evaluation of functional connectivity as a biomarker in the evolution of FRDA | From enrollment to the end of treatment at 3 to 4 weeks and after 1 year of follow-up |
| Measure | Description | Time Frame |
|---|---|---|
| Correlation between functional connectivity/activity and quantitative parameters derived from neuropsychological scales. Correlation between functional connectivity/activity and quantitative parameters derived from motor scales (SARA and mFARS). |
|
Not provided
Inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Gabriella Paparella, Medical Degree | Contact | +39 04389062 | gabriella.paparella@lanostrafamiglia.it |
| Name | Affiliation | Role |
|---|---|---|
| Gabriella Paparella, Medical Doctor | IRCCS E. Medea / Associazione la Nostra Famiglia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| IRCCS Eugenio Medea / Associazione la Nostra Famiglia | Recruiting | Conegliano | Treviso | 31015 | Italy |
Anonymized individual participant data will be shared with other researchers upon reasonable request
Start date: January 2028 End date: January 2038
Any researchers accredited by non-profit clinical and research center
Not provided
Not provided
| ID | Term |
|---|---|
| D005621 | Friedreich Ataxia |
| D000068079 | Motor Disorders |
| D019636 | Neurodegenerative Diseases |
| D002526 | Cerebellar Diseases |
| ID | Term |
|---|---|
| D013132 | Spinocerebellar Degenerations |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| From enrollment to the end of treatment at 3 to 4 weeks and after 1 year of follow-up |
| D013118 | Spinal Cord Diseases |
| D020271 | Heredodegenerative Disorders, Nervous System |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D028361 | Mitochondrial Diseases |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D001523 | Mental Disorders |